| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Iatrou C | |
| Demopoulos CA | |||
| Frangia C | |||
| Tsoupras AB | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 390-399 | |
| P577 | publication date | 2009-08-01 | |
| P1433 | published in | Infectious disorders drug targets | Q27020376 |
| P1476 | title | The implication of platelet activating factor in cancer growth and metastasis: potent beneficial role of PAF-inhibitors and antioxidants | |
| P478 | volume | 9 |
| Q33552144 | A Review on Platelet Activating Factor Inhibitors: Could a New Class of Potent Metal-Based Anti-Inflammatory Drugs Induce Anticancer Properties? |
| Q47710637 | Aberrant lipid metabolism in cancer cells - the role of oncolipid-activated signaling |
| Q59694186 | Angiogenesis and melanoma |
| Q92670725 | Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker? |
| Q52726924 | Atorvastatin prevents glomerular extracellular matrix formation by interfering with the PKC signaling pathway. |
| Q37338408 | Cancer cells incorporate and remodel exogenous palmitate into structural and oncogenic signaling lipids |
| Q35993392 | Computational Identification of Key Regulators in Two Different Colorectal Cancer Cell Lines. |
| Q38950607 | Current Understanding of Platelet-Activating Factor Signaling in Central Nervous System Diseases. |
| Q52689356 | Effects of Platelet-Activating Factor on Brain Microvascular Endothelial Cells. |
| Q50513044 | Effects of highly active antiretroviral therapy on platelet activating factor metabolism in naive HIV-infected patients: ii) study of the abacavir/lamivudine/efavirenz HAART regimen. |
| Q35915423 | Expression of PAFR as part of a prosurvival response to chemotherapy: a novel target for combination therapy in melanoma. |
| Q91807444 | Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives |
| Q41896936 | Hypoxia and hyperoxia potentiate PAF receptor-mediated effects in newborn ovine pulmonary arterial smooth muscle cells: significance in oxygen therapy of PPHN. |
| Q58079350 | In Vitro Anti-Atherogenic Properties of N-Heterocyclic Carbene Aurate(I) Compounds |
| Q35183189 | In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin |
| Q46352349 | In vitro effects of vitamin supplements on platelet-activating factor and its metabolism in age-related macular degeneration |
| Q55446683 | Inflammation, not Cholesterol, Is a Cause of Chronic Disease. |
| Q35214355 | Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor |
| Q38772293 | Mechanism by which nuclear factor-kappa beta (NF-kB) regulates ovine fetal pulmonary vascular smooth muscle cell proliferation |
| Q33805225 | Metal complexes as potential modulators of inflammatory and autoimmune responses |
| Q49636083 | Modulation of Tumor-Associated Macrophages (TAM) Phenotype by Platelet-Activating Factor (PAF) Receptor |
| Q28540983 | Palliation of bone cancer pain by antagonists of platelet-activating factor receptors |
| Q47840702 | Phospholipids of Animal and Marine Origin: Structure, Function, and Anti-Inflammatory Properties. |
| Q57475442 | Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy |
| Q60933523 | Platelet aggregometry assay for evaluating the effects of platelet agonists and antiplatelet compounds on platelet function |
| Q44964344 | Platelet-activating factor and its basic metabolic enzymes in blood of naive HIV-infected patients. |
| Q36346908 | Platelet-activating factor induces cell cycle arrest and disrupts the DNA damage response in mast cells |
| Q58161307 | Progress in the Development of Platelet-Activating Factor Receptor (PAFr) Antagonists and Applications in the Treatment of Inflammatory Diseases |
| Q43428264 | Quantitative Platelet Abnormalities in Patients With Hepatitis B Virus-Related Liver Disease |
| Q39487878 | Reduced group IVA phospholipase A2 expression is associated with unfavorable outcome for patients with gastric cancer |
| Q36240870 | Sphingosine-1-phosphate and other lipid mediators generated by mast cells as critical players in allergy and mast cell function |
| Q55470328 | Structural Elucidation of Irish Organic Farmed Salmon (Salmo salar) Polar Lipids with Antithrombotic Activities. |
| Q34002901 | Structurally diverse metal coordination compounds, bearing imidodiphosphinate and diphosphinoamine ligands, as potential inhibitors of the platelet activating factor. |
| Q33826633 | Systemic Platelet-activating Factor Receptor Activation Augments Experimental Lung Tumor Growth and Metastasis |
| Q90736662 | The Effects of Oxidation on the Antithrombotic Properties of Tea Lipids Against PAF, Thrombin, Collagen, and ADP |
| Q38988569 | The immunomodulatory potential of Leonurus cardiaca extract in relation to endothelial cells and platelets |
| Q33574461 | Tumor macroenvironment and metabolism |
| Q21131368 | Type I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lung |
Search more.